Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

24

Apr 2019

UroGen Pharma Announces Early Stage Feasibility Agreement with Janssen

UroGen Pharma Ltd a clinicalstage biopharmaceutical company developing treatments to address unmet needs in the field of urooncology today announced that it has entered into an agreement with Janssen Research Development LLC Janssen to conduct an earlystage feasibility evaluation in a therapeutic a...

24

Apr 2019

Lilly and Avidity Biosciences Announce Licensing and Research Collaboration

Eli Lilly and Company and Avidity Biosciences Inc today announced a global licensing and research collaboration focused on the discovery development and commercialization of potential new medicines in immunology and other select indications

23

Apr 2019

Elpiscience and Bio-Techne Announce Strategic Collaboration

Elpiscience BioPharma and BioTechne Corporation announced today that the companies have entered into a strategic collaboration for the development of anticancer therapeutics

23

Apr 2019

Oakrum Pharma and Biophore Announce Product Development and Commercialization Partnership

Oakrum Pharma LLC Oakrum announced today that it has entered into an agreement with Biophore India Pharmaceuticals Pvt Ltd Biophore to develop and manufacture two prescription generic pharmaceutical products that are intended to be commercialized in the US under the Oakrum label

20

Apr 2019

TB Alliance and Mylan Announce Global Collaboration

Nonprofit drug developer TB Alliance and pharmaceutical company Mylan NV NASDAQ MYL today announced a global collaboration to make the experimental drug pretomanid accessible for use in two investigational drug regimens for pulmonary tuberculosis TB TB a bacterial infection transmitted through the a...

press releasesRead more...

24

Apr 2019

Velabs Therapeutics to Cooperate with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening

Velabs Therapeutics specializing in the fast generation of functional therapeutic antibodies today announced that it has entered into an agreement with Chiome Bioscience Inc Tokyo to jointly discover modulatory and functional antibodies for one of Chiomes GPCR target genes

24

Apr 2019

Macrogen and Exosome Plus sign MOU for joint development of exosome-based diagnostic and therapeutic agents

Macrogen a precision medicine and biotechnology company is on April th on Exosome Plus P John Wook announced a contract for exclusive supply of exosome isolation kit and announced on April that it has signed a business agreement on joint development of an exosomebased diagnostic and therapeutic age...

24

Apr 2019

EpimAb Biotherapeutics is Granted US Patent on Core Bispecific Antibody Technology

EpimAb Biotherapeutics an emerging biopharmaceutical company based in Shanghai announced today that the United States Patent and Trademark Office USPTO has granted the US Patent No entitled FabsInTandem Immunoglobulin and Uses Thereof Based on EpimAbs globally filed first application this patent br...

23

Apr 2019

Vineti and Marker Therapeutics announce strategic partnership to support diverse cell therapy portfolio

Vineti Inc the leading software platform of record for personalized therapeutics today announced a new partnership to advance and scale Marker Therapeutics T cell therapy pipeline

23

Apr 2019

Tonix Pharmaceuticals Announces that Breakthrough Therapy Designation Remains in Effect for Tonmya® for the Treatment of Posttraumatic Stress Disorder

Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company developing pharmaceutical products to treat psychiatric and pain conditions and biological products to improve biodefense

EventsRead more...

22 - 25

Apr 2019

3rd Annual NASH Summit

Hanson Wade
Hilton Boston Logan Airport

22 - 24

Apr 2019

22 - 24

Apr 2019

20th Asia-Pacific Pharma Congress

Conference Series LLC Ltd
Radisson Hotel Narita

23 - 25

Apr 2019

3rd Annual European NeoAg Summit

Hanson Wade
Amsterdam Marriott Hotel

Advertisements

TOP ARTICLES

  • 4

    Are you Ready for EU FMD?

    With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel ex...

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...
  • Articles

    Nanomedicines management for advance therapy of NeuroAIDS: State of art

    Introduction The Human Immune deficiency Virus HIV infected brain cells through virus or HIV linked oncogenes The major complication of such infection leads to dementia peripheral neuropathies neurosyphilis meningitis etc The development of neuroAIDS still remains a topic of debate due to multifaceted symptom complicated pathology alon

EDITORIAL SECTION